HBIO Stock Analysis: Buy, Sell, or Hold?
HBIO - Harvard Bioscience Inc
$5.20
0.11 (2.16%)
▲
5d:
+2.56%
30d:
+806.56%
90d:
+677.51%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
HBIO is down 13.5% this week, but smart money is accumulating calls. Top strike: $0.5 2026-05-15 with 1,008 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When HBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: HBIO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$10.91
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.77
23.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HBIO is currently trading at $5.20, which is considered extended relative to its 30-day fair value range of $0.55 to $5.08. The stock's valuation (Forward PE: 6.5) is in line with its historical norms (7.0). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $4.56, while resistance sits at $5.49.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+15.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HBIO is in a strong uptrend. Immediate support is located at $4.56, while resistance sits at $5.49.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.00 (+15.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.55 -
$5.08
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($6.00)
Fair Price Analysis
30-Day Fair Range
$0.55 -
$5.08
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$4.56
Resistance Level
$5.49
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.50
Wall Street Target
$6.00
(+15.4%)
Revenue Growth (YoY)
-3.3%
Earnings Growth (YoY)
-80.3%
Profit Margin
-65.5%
Valuation Discount vs History
-2.6% cheaper
PE vs Historical
6.5 vs 7.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.6%
(market-implied from PE analysis)
1-Year Target
$5.06
(-3%)
2-Year Target
$4.93
(-5%)
3-Year Target
$4.80
(-8%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
$5.17
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.6, Growth: 300.0%)
$55.54
(+968%)
Base:
(SPY PE: 6.5, Growth: 300.0%)
$17.55
(+238%)
Bear:
(PE: 5.5, Growth: 300.0%)
$14.92
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.5 to 7.0
Stabilization Target:
$5.60
(+7.7%)
PE Expansion Potential:
+7.7%
Share & Embed Analysis
Last updated: April 04, 2026 6:55 AM ET
Data refreshes hourly during market hours. Next update: 7:55 AM
Data refreshes hourly during market hours. Next update: 7:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HBIO showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen J Denelsky
BUY
10000 shares
2026-03-17
William Snider
BUY
8475 shares
2026-03-17
John D Duke
BUY
5000 shares
2026-03-16
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 60 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 61 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 65 BUY |
